Point72 Europe (London) LLP Bruker Corp Transaction History
Point72 Europe (London) LLP
- $1.1 Billion
- Q2 2024
A detailed history of Point72 Europe (London) LLP transactions in Bruker Corp stock. As of the latest transaction made, Point72 Europe (London) LLP holds 333,997 shares of BRKR stock, worth $23.6 Million. This represents 1.94% of its overall portfolio holdings.
Number of Shares
333,997
Previous 92,038
262.89%
Holding current value
$23.6 Million
Previous $8.65 Million
146.5%
% of portfolio
1.94%
Previous 0.81%
Shares
3 transactions
Others Institutions Holding BRKR
# of Institutions
384Shares Held
104MCall Options Held
138KPut Options Held
26.4K-
T. Rowe Price Investment Management, Inc. Baltimore, MD13.5MShares$957 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$770 Million0.01% of portfolio
-
Black Rock Inc. New York, NY9.83MShares$695 Million0.01% of portfolio
-
Pallas Capital Advisors LLC Braintree, MA9.48MShares$670 Million26.1% of portfolio
-
Massachusetts Financial Services CO Boston, MA6.36MShares$450 Million0.13% of portfolio
About BRUKER CORP
- Ticker BRKR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 148,138,000
- Market Cap $10.5B
- Description
- Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...